Immunoprecipitation-targeted proteomics assays facilitate rational development of SARS-CoV-2 serological diagnostics

Zhiqiang Fu, Yasmine Rais, Andrei P. Drabovich
doi: https://doi.org/10.1101/2021.10.25.21265408

Article Information

doi 
https://doi.org/10.1101/2021.10.25.21265408
History 
  • October 26, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Zhiqiang Fu1,*,
  2. Yasmine Rais1,* and
  3. Andrei P. Drabovich1,**
  1. 1Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada T6G 2G3
  1. ↵**Correspondence to: A. P. Drabovich, Ph.D., Department of Laboratory Medicine and Pathology, University of Alberta, 10-102 Clinical Sciences Building, Edmonton, Alberta, Canada T6G 2G3. Tel: 780-492-1190; e-mail: andrei.drabovich{at}ualberta.ca

  1. ↵* Contributed equally

Back to top
Posted October 26, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Immunoprecipitation-targeted proteomics assays facilitate rational development of SARS-CoV-2 serological diagnostics
Zhiqiang Fu, Yasmine Rais, Andrei P. Drabovich
medRxiv 2021.10.25.21265408; doi: https://doi.org/10.1101/2021.10.25.21265408
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area